Late Breaking Abstract

15 Apr 2024 5:45 p.m. 6:45 p.m.

MON-296 to MON-304

Neil Boudville Poster Moderator

Time	Session

5:45 p.m. 6:45 p.m.	SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL WCN24-AB-847, Poster Board= MON-296 MON-296 Jonathan Barratt Poster Presenter	VALIDITY OF RENAL DOPPLER RESISTIVITY INDEX IN RENAL ALLOGRAFT INFECTION WCN24-AB-769, Poster Board= MON-297 MON-297	MYELOMA KIDNEY: A RARE ENTITY IN PATIENTS IN THE FIFTH DECADE OF LIFE RELATING TO A CASE AND REVIEW OF THE LITERATURE. WCN24-AB-1793, Poster Board= MON-298 MON-298 Alejandra Galvan Ruiz Poster Presenter	The clinical and health economic effect of a 6-month physical activity digital health intervention on health-related quality of life in people with chronic kidney disease WCN24-AB-1556, Poster Board= MON-299 MON-299	EPIDEMIOLOGICAL PROFILE OF KDIGO STAGE III ACUTE KIDNEY INJURY WITH THE NEED FOR RENAL SUPPORT THERAPY IN THE INTENSIVE CARE UNIT: OUR EXPERIENCE WCN24-AB-2582, Poster Board= MON-300 MON-300	COMPARING HORSE VS RABBIT ATG AS INDUCTION THERAPY IN KIDNEY TRANSPLANT WCN24-AB-2364, Poster Board= MON-301 MON-301 Pavan Kumar Rao Navva Poster Presenter	EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY WCN24-AB-1506, Poster Board= MON-302 MON-302 Dana Rizk Poster Presenter	Predicting the risks of kidney failure and death in adults with moderate-to-severe chronic kidney disease (KDpredict) WCN24-AB-2729, Poster Board= MON-303 MON-303 Pietro Ravani Poster Presenter	UPDATED RESULTS FROM THE RUBY-3 STUDY OF POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS WCN24-AB-762, Poster Board= MON-304 MON-304 James Tumlin Poster Presenter